Diversified use of Non-invasive Biomarkers in Study Protocol and Screen failure in Non-Alcoholic Steatohepatitis (NASH)

This study examines how non-invasive biomarkers of NASH are introduced into the study protocol and whether this has an impact on screen failure. The study will investigate the use of non-invasive biomarkers in the design of study protocols for NASH drug trials and will also examine if screening approaches established using non-invasive biomarkers can reduce screen failure.

Author dc:creator

• Masaye, Nikita P.

Contributors dc:contributor

• Gregory, Paula

• NASH

Language dc:language

en

Handle dc:identifier.uri

https://hdl.handle.net/20.500.12503/32460

OAI identifier oai:identifier

oai:tdl-ir.tdl.org:20.500.12503/32460